These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29518414)

  • 21. Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel.
    Li F; Ma C; DeGrado WF; Wang J
    J Med Chem; 2016 Feb; 59(3):1207-16. PubMed ID: 26771709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amantadine resistance among highly pathogenic avian influenza viruses (H5N1) isolated from India.
    Jacob A; Sood R; Chanu KhV; Bhatia S; Khandia R; Pateriya AK; Nagarajan S; Dimri U; Kulkarni DD
    Microb Pathog; 2016 Feb; 91():35-40. PubMed ID: 26639679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the Drug Resistance Mechanism of M2-S31N Channel Blockers through Biomolecular Simulations and Viral Passage Experiments.
    Musharrafieh R; Lagarias P; Ma C; Hau R; Romano A; Lambrinidis G; Kolocouris A; Wang J
    ACS Pharmacol Transl Sci; 2020 Aug; 3(4):666-675. PubMed ID: 32832869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
    Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of amantadine-resistant influenza A virus isolated in Gyeonggi Province, South Korea, during 2005-2010.
    Cho HG; Choi JH; Kim WH; Hong HK; Yoon MH; Jho EH; Kang C; Lim YH
    Arch Virol; 2013 Jan; 158(1):241-5. PubMed ID: 23011311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why amantadine loses its function in influenza m2 mutants: MD simulations.
    Laohpongspaisan C; Rungrotmongkol T; Intharathep P; Malaisree M; Decha P; Aruksakunwong O; Sompornpisut P; Hannongbua S
    J Chem Inf Model; 2009 Apr; 49(4):847-52. PubMed ID: 19281265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA; Bovin NV; Webster RG; Govorkova EA
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001.
    Schmidtke M; Zell R; Bauer K; Krumbholz A; Schrader C; Suess J; Wutzler P
    Intervirology; 2006; 49(5):286-93. PubMed ID: 16809934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.
    McKimm-Breschkin JL; Rootes C; Mohr PG; Barrett S; Streltsov VA
    J Antimicrob Chemother; 2012 Aug; 67(8):1874-83. PubMed ID: 22563014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divalent copper complexes as influenza A M2 inhibitors.
    Gordon NA; McGuire KL; Wallentine SK; Mohl GA; Lynch JD; Harrison RG; Busath DD
    Antiviral Res; 2017 Nov; 147():100-106. PubMed ID: 29032206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.
    Abed Y; Pizzorno A; Bouhy X; Boivin G
    Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of molecular markers of amantadine resistance in swine influenza viruses by pyrosequencing].
    Liu H; Lv Y; Huang W; Yan M; Zhang W; Li M; Wang Q; Li J; Zheng D; Zhao Y; Sun C; Wang Z
    Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):395-9. PubMed ID: 20499646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
    Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
    Rey-Carrizo M; Torres E; Ma C; Barniol-Xicota M; Wang J; Wu Y; Naesens L; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
    J Med Chem; 2013 Nov; 56(22):9265-74. PubMed ID: 24237039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology and spread of drug resistant human influenza viruses.
    Hurt AC
    Curr Opin Virol; 2014 Oct; 8():22-9. PubMed ID: 24866471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High resolution melting analysis as a tool to detect molecular markers of antiviral resistance in influenza A viruses.
    Arvia R; Corcioli F; Azzi A
    J Virol Methods; 2013 May; 189(2):265-70. PubMed ID: 23499313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
    Hurt AC; Selleck P; Komadina N; Shaw R; Brown L; Barr IG
    Antiviral Res; 2007 Mar; 73(3):228-31. PubMed ID: 17112602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug-resistant influenza viruses: an overview].
    Hatakeyama S
    Nihon Rinsho; 2010 Sep; 68(9):1671-8. PubMed ID: 20845746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
    Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
    Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.